All Stories

  1. Natural history of a parasite-induced biliary cancer
  2. The Hidden Hand of Asymptomatic Infection Hinders Control of Neglected Tropical Diseases: A Modeling Analysis
  3. How does the proportion of never treatment influence the success of mass drug administration programmes for the elimination of lymphatic filariasis?
  4. Persons ‘never treated’ in mass drug administration for lymphatic filariasis: identifying programmatic and research needs from a series of research review meetings 2020–2021
  5. The hidden hand of asymptomatic infection hinders control of neglected tropical diseases
  6. A modelling analysis of a new multi-stage pathway for classifying achievement of public health milestones for leprosy
  7. Introduction to the special issue: challenges and opportunities in the fight against neglected tropical diseases: a decade from the London Declaration on NTDs
  8. Diagnosis of helminths depends on worm fecundity and the distribution of parasites within hosts
  9. Health economic analyses of latent tuberculosis infection screening and preventive treatment among people living with HIV in lower tuberculosis incidence settings: a systematic review
  10. Estimating LFT and qPCR test-sensitivity over time since infection from a human challenge study
  11. An archetypes approach to malaria intervention impact mapping: a new framework and example application
  12. Impact of intensified control on visceral leishmaniasis in a highly-endemic district of Bihar, India: An interrupted time series analysis
  13. Gender-related differences in prevalence, intensity and associated risk factors of Schistosoma infections in Africa: A systematic review and meta-analysis
  14. The SARS-CoV-2 pandemic: remaining uncertainties in our understanding of the epidemiology and transmission dynamics of the virus, and challenges to be overcome
  15. Estimating HIV, HCV and HSV2 incidence from emergency department serosurvey
  16. How modelling can help steer the course set by the World Health Organization 2021-2030 roadmap on neglected tropical diseases
  17. Sustainable Surveillance of Neglected Tropical Diseases for the Post-Elimination Era
  18. Maintaining Low Prevalence of Schistosoma mansoni: Modeling the Effect of Less Frequent Treatment
  19. Forecasting Trachoma Control and Identifying Transmission-Hotspots
  20. What Can Modeling Tell Us About Sustainable End Points for Neglected Tropical Diseases?
  21. Modelling the Impact of Vector Control on Lymphatic Filariasis Programs: Current Approaches and Limitations
  22. Dynamics of SARS-CoV-2 with waning immunity in the UK population
  23. Engagement and adherence trade-offs for SARS-CoV-2 contact tracing
  24. Epidemic interventions: insights from classic results
  25. Strengthening data collection for neglected tropical diseases: What data are needed for models to better inform tailored intervention programmes?
  26. Health economic analyses of latent tuberculosis infection screening and preventive treatment among people living with HIV in lower tuberculosis incidence settings: a systematic review
  27. Evaluating the potential impact of interruptions to neglected tropical disease programmes due to COVID-19
  28. Modelling trachoma post-2020: opportunities for mitigating the impact of COVID-19 and accelerating progress towards elimination
  29. SCHISTOX: An individual based model for the epidemiology and control of schistosomiasis
  30. Delays in lymphatic filariasis elimination programmes due to COVID-19, and possible mitigation strategies
  31. Disruptions to schistosomiasis programmes due to COVID-19: an analysis of potential impact and mitigation strategies
  32. Implications of the COVID-19 pandemic in eliminating trachoma as a public health problem
  33. Towards Evidence-based Control of Opisthorchis viverrini
  34. Forecasting trachoma control and identifying transmission-hotspots
  35. Responsible modelling: Unit testing for infectious disease epidemiology
  36. The impact of mass drug administration on Schistosoma haematobium infection: what is required to achieve morbidity control and elimination?
  37. Towards a comprehensive research and development plan to support the control, elimination and eradication of neglected tropical diseases
  38. Predicting the impact of disruptions in lymphatic filariasis elimination programmes due to the outbreak of coronavirus disease (COVID-19) and possible mitigation strategies
  39. Statistical methods for linking geostatistical maps and transmission models: Application to lymphatic filariasis in East Africa
  40. Modelling trachoma post 2020: Opportunities for mitigating the impact of COVID-19 and accelerating progress towards elimination
  41. Disruptions to schistosomiasis programmes due to COVID-19: an analysis of potential impact and mitigation strategies
  42. A novel age-structured mosquito model for assessing the mechanisms behind vector control success
  43. Defining a prevalence level to describe the elimination of Lymphatic Filariasis (LF) transmission and designing monitoring & evaluating (M&E) programmes post the cessation of mass drug administration (MDA)
  44. Predicted Impact of COVID-19 on Neglected Tropical Disease Programs and the Opportunity for Innovation
  45. Estimating how far and fast visceral leishmaniasis spreads around cases
  46. Engagement and adherence trade-offs for SARS-CoV-2 contact tracing
  47. Responsible modelling: Unit testing for infectious disease epidemiology
  48. Key questions for modelling COVID-19 exit strategies
  49. Integrating geostatistical maps and transmission models using adaptive multiple importance sampling
  50. COVID-19 spread in the UK: the end of the beginning?
  51. Dynamics of SARS-CoV-2 with Waning Immunity in the UK Population
  52. Efficacy of contact tracing for the containment of the 2019 novel coronavirus (COVID-19)
  53. A novel age-structured mosquito model for assessing the mechanisms behind vector control success
  54. An imperfect tool: COVID-19 ‘test & trace’ success relies on minimising the impact of false negatives and continuation of physical distancing
  55. When, Who, and How to Sample: Designing Practical Surveillance for 7 Neglected Tropical Diseases as We Approach Elimination
  56. Policy implications of the potential use of a novel vaccine to prevent infection with Schistosoma mansoni with or without mass drug administration
  57. How universal does universal test and treat have to be?
  58. Erratum to: Trachoma Prevalence After Discontinuation of Mass Azithromycin Distribution
  59. The use of mixture density networks in the emulation of complex epidemiological individual-based models
  60. Developments in statistical inference when assessing spatiotemporal disease clustering with the tau statistic
  61. How will country-based mitigation measures influence the course of the COVID-19 epidemic?
  62. Inferring transmission trees to guide targeting of interventions against visceral leishmaniasis and post-kala-azar dermal leishmaniasis
  63. The Efficacy of Contact Tracing for the Containment of the 2019 Novel Coronavirus (COVID-19).
  64. Trachoma Prevalence After Discontinuation of Mass Azithromycin Distribution
  65. Elimination or Resurgence: Modelling Lymphatic Filariasis After Reaching the 1% Microfilaremia Prevalence Threshold
  66. Achieving Elimination as a Public Health Problem for Schistosoma mansoni and S. haematobium: When Is Community-Wide Treatment Required?
  67. Mass deworming for improving health and cognition of children in endemic helminth areas: A systematic review and individual participant data network meta‐analysis
  68. Insights from quantitative and mathematical modelling on the proposed WHO 2030 goal for schistosomiasis
  69. Insights from mathematical modelling and quantitative analysis on the proposed WHO 2030 targets for visceral leishmaniasis on the Indian subcontinent
  70. Vaccination or mass drug administration against schistosomiasis: a hypothetical cost-effectiveness modelling comparison
  71. The roadmap towards elimination of lymphatic filariasis by 2030: insights from quantitative and mathematical modelling
  72. Evaluating the Evidence for Lymphatic Filariasis Elimination
  73. Guidelines for multi-model comparisons of the impact of infectious disease interventions
  74. Insights from quantitative and mathematical modelling on the proposed WHO 2030 goal for schistosomiasis
  75. Deworming children for soil-transmitted helminths in low and middle-income countries: systematic review and individual participant data network meta-analysis
  76. Community-based testing of migrants for infectious diseases (COMBAT-ID): impact, acceptability and cost-effectiveness of identifying infectious diseases among migrants in primary care: protocol for an interrupted time-series, qualitative and health eco...
  77. The use of mixture-density networks in the emulation of complex epidemiological individual-based models
  78. Age trends in asymptomatic and symptomatic Leishmania donovani infection in the Indian subcontinent: A review and analysis of data from diagnostic and epidemiological studies
  79. Identifying English Practices that Are High Antibiotic Prescribers Accounting for Comorbidities and Other Legitimate Medical Reasons for Variation
  80. Optimising sampling regimes and data collection to inform surveillance for trachoma control
  81. Quantifying the value of surveillance data for improving model predictions of lymphatic filariasis elimination
  82. The role of case proximity in transmission of visceral leishmaniasis in a highly endemic village in Bangladesh
  83. The impact of seasonality on the dynamics and control of Ascaris lumbricoides infections
  84. Correction to: The Dynamics of Ascaris lumbricoides Infections
  85. Complex interactions in soil-transmitted helminth co-infections from a cross-sectional study in Sri Lanka
  86. Diagnosing risk factors alongside mass drug administration using serial diagnostic tests—which test first?
  87. Counting Down the 2020 Goals for 9 Neglected Tropical Diseases: What Have We Learned From Quantitative Analysis and Transmission Modeling?
  88. Are Alternative Strategies Required to Accelerate the Global Elimination of Lymphatic Filariasis? Insights From Mathematical Models
  89. Assessing Strategies Against Gambiense Sleeping Sickness Through Mathematical Modeling
  90. Models of Trachoma Transmission and Their Policy Implications: From Control to Elimination
  91. Policy Lessons From Quantitative Modeling of Leprosy
  92. Policy Recommendations From Transmission Modeling for the Elimination of Visceral Leishmaniasis in the Indian Subcontinent
  93. Kernel-density estimation and approximate Bayesian computation for flexible epidemiological model fitting in Python
  94. Economic evaluations of lymphatic filariasis interventions: a systematic review and research needs
  95. Understanding heterogeneities in mosquito-bite exposure and infection distributions for the elimination of lymphatic filariasis
  96. Seasonally timed treatment programs for Ascaris lumbricoides to increase impact—An investigation using mathematical models
  97. Understanding the relationship between egg- and antigen-based diagnostics of Schistosoma mansoni infection pre- and post-treatment in Uganda
  98. 100 Years of Mass Deworming Programmes: A Policy Perspective From the World Bank's Disease Control Priorities Analyses
  99. Variations in visceral leishmaniasis burden, mortality and the pathway to care within Bihar, India
  100. Mass Deworming Programs in Middle Childhood and Adolescence
  101. Targeted Treatment of Yaws With Household Contact Tracing: How Much Do We Miss?
  102. Economic Evaluations of Mass Drug Administration: The Importance of Economies of Scale and Scope
  103. Investment in child and adolescent health and development: key messages from Disease Control Priorities , 3rd Edition
  104. Cost-effectiveness of screening for HIV in primary care: a health economics modelling analysis
  105. Innovative tools and approaches to end the transmission of Mycobacterium leprae
  106. Economic Considerations for Moving beyond the Kato-Katz Technique for Diagnosing Intestinal Parasites As We Move Towards Elimination
  107. Effectiveness of a triple-drug regimen for global elimination of lymphatic filariasis: a modelling study
  108. Elimination of visceral leishmaniasis in the Indian subcontinent: a comparison of predictions from three transmission models
  109. Learning from multi-model comparisons: Collaboration leads to insights, but limitations remain
  110. Measuring and modelling the effects of systematic non-adherence to mass drug administration
  111. Predicting lymphatic filariasis transmission and elimination dynamics using a multi-model ensemble framework
  112. Making Transmission Models Accessible to End-Users: The Example of TRANSFIL
  113. Retinal pigment epithelium and microglia express the CD5 antigen-like protein, a novel autoantigen in age-related macular degeneration
  114. A strengthening evidence-base for mass deworming, but questions remain
  115. Development and evaluation of a Markov model to predict changes in schistosomiasis prevalence in response to praziquantel treatment: a case study of Schistosoma mansoni in Uganda and Mali
  116. Cost-effectiveness of scaling up mass drug administration for the control of soil-transmitted helminths: a comparison of cost function and constant costs analyses
  117. Analysis of the population-level impact of co-administering ivermectin with albendazole or mebendazole for the control and elimination of Trichuris trichiura
  118. Understanding the relationship between prevalence of microfilariae and antigenaemia using a model of lymphatic filariasis infection
  119. Key traveller groups of relevance to spatial malaria transmission: a survey of movement patterns in four sub-Saharan African countries
  120. The Dynamics of Ascaris lumbricoides Infections
  121. Understanding the relationship between prevalence of microfilariae and antigenaemia using a model of lymphatic filariasis infection
  122. Understanding the transmission dynamics of Leishmania donovani to provide robust evidence for interventions to eliminate visceral leishmaniasis in Bihar, India
  123. The Role of More Sensitive Helminth Diagnostics in Mass Drug Administration Campaigns
  124. Circulating Autoantibodies in Age-Related Macular Degeneration Recognize Human Macular Tissue Antigens Implicated in Autophagy, Immunomodulation, and Protection from Oxidative Stress and Apoptosis
  125. Health-seeking behaviour, diagnostics and transmission dynamics in the control of visceral leishmaniasis in the Indian subcontinent
  126. Quantitative analyses and modelling to support achievement of the 2020 goals for nine neglected tropical diseases
  127. Bihar’s Pioneering School-Based Deworming Programme: Lessons Learned in Deworming over 17 Million Indian School-Age Children in One Sustainable Campaign
  128. An economic evaluation of expanding hookworm control strategies to target the whole community
  129. Modelling the distribution and transmission intensity of lymphatic filariasis in sub-Saharan Africa prior to scaling up interventions: integrated use of geostatistical and mathematical modelling
  130. Modelling strategies to break transmission of lymphatic filariasis - aggregation, adherence and vector competence greatly alter elimination
  131. Quantification of the natural history of visceral leishmaniasis and consequences for control
  132. Interrupting transmission of soil-transmitted helminths: a study protocol for cluster randomised trials evaluating alternative treatment strategies and delivery systems in Kenya
  133. MDA helminth control: more questions than answers
  134. Should the Goal for the Treatment of Soil Transmitted Helminth (STH) Infections Be Changed from Morbidity Control in Children to Community-Wide Transmission Elimination?
  135. Simple Approximations for Epidemics with Exponential and Fixed Infectious Periods
  136. Cost and cost-effectiveness of soil-transmitted helminth treatment programmes: systematic review and research needs
  137. Uniting mathematics and biology for control of visceral leishmaniasis
  138. Brief Report
  139. Modeling infectious disease dynamics in the complex landscape of global health
  140. Six challenges in the eradication of infectious diseases
  141. Seven challenges in modeling vaccine preventable diseases
  142. Seven challenges for model-driven data collection in experimental and observational studies
  143. Seven challenges for modelling indirect transmission: Vector-borne diseases, macroparasites and neglected tropical diseases
  144. Gradual acquisition of immunity to severe malaria with increasing exposure
  145. Fit for purpose: do we have the right tools to sustain NTD elimination?
  146. Infectious disease and health systems modelling for local decision making to control neglected tropical diseases
  147. Mass Drug Administration and beyond: how can we strengthen health systems to deliver complex interventions to eliminate neglected tropical diseases?
  148. High Transmissibility During Early HIV Infection Among Men Who Have Sex With Men—San Francisco, California: Table 1.
  149. Modeling the Interruption of the Transmission of Soil-Transmitted Helminths by Repeated Mass Chemotherapy of School-Age Children
  150. The coverage and frequency of mass drug administration required to eliminate persistent transmission of soil-transmitted helminths
  151. Virulence and Pathogenesis of HIV-1 Infection: An Evolutionary Perspective
  152. Can chemotherapy alone eliminate the transmission of soil transmitted helminths?
  153. UK malaria: increased risk for those visiting friends and relatives, business travellers & children
  154. How Effective Is School-Based Deworming for the Community-Wide Control of Soil-Transmitted Helminths?
  155. Heterosexual HIV-1 Infectiousness and Antiretroviral Use
  156. Transmission Dynamics of Ascaris lumbricoides – Theory and Observation
  157. Corrigendum to “27 years of the HIV epidemic amongst men having sex with men in the Netherlands: An in depth mathematical model-based analysis” [Epidemics 2 (2010) 66–79]
  158. Department of Error
  159. Optimisation of mass chemotherapy to control soil-transmitted helminth infection
  160. The Potential Contribution of Mass Treatment to the Control of Plasmodium falciparum Malaria
  161. Mitigation Strategies for Pandemic Influenza A: Balancing Conflicting Policy Objectives
  162. Interpretation of correlations in setpoint viral load in transmitting couples
  163. Reducing Plasmodium falciparum Malaria Transmission in Africa: A Model-Based Evaluation of Intervention Strategies
  164. 27 years of the HIV epidemic amongst men having sex with men in the Netherlands: An in depth mathematical model-based analysis
  165. HIV-1 Transmitting Couples Have Similar Viral Load Set-Points in Rakai, Uganda
  166. Modelling the between-host evolution of set-point viral load in HIV infection
  167. Corrigendum to “Variational data assimilation with epidemic models” [J. Theor. Biol. 258 (2009) 591–602]
  168. Controlling infectious disease outbreaks: Lessons from mathematical modelling
  169. Response--Influenza
  170. Variational data assimilation with epidemic models
  171. Pandemic Potential of a Strain of Influenza A (H1N1): Early Findings
  172. Estimating the public health impact of the effect of herpes simplex virus suppressive therapy on plasma HIV-1 viral load
  173. 6.16 Mathematical models of transmission and control
  174. HIV-1 Transmission, by Stage of Infection
  175. A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy
  176. Variation in HIV-1 set-point viral load: Epidemiological analysis and an evolutionary hypothesis
  177. Frequent Travelers and Rate of Spread of Epidemics
  178. Will travel restrictions control the international spread of pandemic influenza?
  179. A comparison of methods for trend estimation